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Bacteria evolving resistance against the action of multiple drugs and its ability to
disseminate the multidrug resistance trait(s) across various strains of the same bacteria
or different bacterial species impose serious threat to public health. Evolution of such
multidrug resistance is due to the fact that, most of the antibiotics target bacterial
survival mechanisms which exert selective pressure on the bacteria and aids them
to escape from the action of antibiotics. Nonetheless, targeting bacterial virulence
strategies such as bacterial surface associated polysaccharides biosynthesis and their
surface accumulation mechanisms may be an attractive strategy, as they impose less
selective pressure on the bacteria. Capsular polysaccharide (CPS) or K-antigen that is
located on the bacterial surface armors bacteria from host immune response. Thus,
unencapsulating bacteria would be a good strategy for drug design, besides CPS itself
being a good vaccine target, by interfering with CPS biosynthesis and surface assembly
pathway. Gram-negative Escherichia coli uses Wzy-polymerase dependent (Groups 1
and 4) and ATP dependent (Groups 1 and 3) pathways for CPS production. Considering
E. coli as a case in point, this review explains the structure and functional roles of
proteins involved in Group 1 Wzy dependent CPS biosynthesis, surface expression and
anchorage in relevance to drug and vaccine developments.
Keywords: antibiotic resistance, antivirulence strategy, capsular polysaccharide, Escherichia coli, Wzy
polymerase dependent pathway, Group 1 CPS, CPS based vaccine
INTRODUCTION
Discovery of antibiotics revolutionized modern medicine by protecting millions of people from
life-threatening bacterial infections (Ventola, 2015). Though antibiotics underpin important
medical advancements in the 20th century, development of resistance against their action to
combat bacterial infections is increasingly common in recent years and thus, emerged as one of the
greatest threats to human health (Davies and Davies, 2010). Indeed, bacteria develop antimicrobial
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resistance (AMR) or antibiotic resistance for more than one
drug, resulting in multidrug resistance (MDR) that further
complicates the issue (Anes et al., 2015). For instance, Klebsiella
pneumoniae, a ‘superbug’ that is responsible for a range of
infections like pneumonia, meningitis, blood stream and surgical
infections, is resistant to third-generation cephalosporins and
carbapenems (WHO, 2014). WHO’s (2014) report on AMR also
states that extensively drug-resistant tuberculosis (XDR-TB) has
increased to 9.2% among the reported MDR-TB cases, wherein,
drugs like rifampicin, ethambutol, pyrazinamide and isoniazid
have become ineffective against the pathogen Mycobacterium
tuberculosis. MDR is increasingly common in recent years and
expensive to treat. It is a great threat to children, elderly
and immunocompromised patients such as those who undergo
chemotherapy. As per the WHO’s (2014) report, 25000 people
in Europe and 23000 in US die annually due to AMR. In fact, a
recent report prepared by economist O’Neill (2016) warns that a




Bacteria exhibit remarkably diverse and complicated mechanisms
against the action of antibiotics. Bacteria can evolve antibiotic
resistance either through intrinsic or acquired mechanisms
(Figure 1). Intrinsic resistance is due to the intrinsic functional
or structural characteristics of the bacterium. For example, due
to the difference in the membrane structure of Gram-positive
and Gram-negative bacteria, lipopeptide daptomycine is good
for treating the former, whereas it is unsuitable to treat the
latter due to inefficiency of daptomycine to get inserted into
the outer membrane (Randall et al., 2013) (Figure 1A). Though
the antibiotic can enter the outer membrane in some cases, the
bacteria can actively pump it out by eﬄux pumps (Webber and
Piddock, 2003) before it reaches the target (Figure 1B). This
mechanism contributes to intrinsic resistance mainly in Gram-
negative bacteria due to the presence of membrane spanning
nanomachineries such as resistance-nodulation-division (RND)
eﬄux pumps (Venter et al., 2015). Due to these reasons many
drugs that are effective in Gram-positive bacteria are ineffective
in Gram-negative bacteria.
ACQUIRED RESISTANCE
Bacteria acquire resistance to antibiotics through chromosomal
gene mutations known as vertical evolution that can subsequently
be transmitted to other bacterial strains through horizontal
gene transfer (HGT) (Poole, 2011; Radhouani et al., 2014;
von Wintersdorff et al., 2016). Three main actions come
under acquired resistance (Figures 1C–E): (1) preventing
the target access by reducing the intracellular accumulation
of antibiotics through poor penetration or increased eﬄux
(Zgurskaya et al., 2015), (2) alternations in antibiotic target
by genetic mutation or post-translational modification and (3)
inactivation of antibiotics through chemical modification (Blair
et al., 2015).
One such example for aforementioned antibiotic refractory
mechanism is resistance to clinically effective antibiotics by
overexpression of eﬄux pumps (Anes et al., 2015; Alcalde-Rico
et al., 2016) (Figure 1C) as found in patients infected with
Enterobacteriaceae family of Gram-negative bacteria (Everett
et al., 1996), Staphylococcus aureus (Kosmidis et al., 2012) etc.
(Pumbwe and Piddock, 2000). Permeability of the antibiotics
(Figure 1A) can also be reduced through the down-regulation
of porins as in Enterobacteriaceae (Lavigne et al., 2013), which
results in resistance to antibiotics like carbapenems (Baroud et al.,
2013). Such antibiotic resistance gene(s) can be mobilized onto
plasmids and transferred between bacteria.
Target site protection (Figure 1D) is yet another mechanism
that bacteria adopt to escape from the antibiotic activity by
changing their target structure, without interfering with their
function, which consequently prevents the specific binding of
antibiotic to the target. Indeed, even a point mutation in the
gene can confer antibiotic resistance that can subsequently
proliferate within the strain. Fluoroquinolone resistance in
Enteroaggregative Escherichia coli (EAEC) (Kim et al., 2012) is
also due to single or multiple mutations in quinolone resistance
determining regions (Taneja et al., 2015). Target change can
also be achieved through the acquisition of a homologues
gene that is similar to the target gene. This resistance gene
can also be disseminated across various strains and species
through horizontal gene transfer through DNA uptake from
the environment. Addition of chemical groups to the target site
(Figure 1D) also offers resistance to antibiotics. For instance,
chloramphenicol-florfenicol resistant (crf) methyltransferase
(Shen et al., 2013) in E. coli.
Bacteria can also escape the antibiotics by destroying
the antibiotics or modifying the structure by transfer of
chemical groups to the antibiotics (Figure 1E). Enzymes such
as β-lactamase (Abraham and Chain, 1988), carbapenemase
(Tzouvelekis et al., 2012), imipenemase and New Delhi metallo-
β-lactamase (Nordmann et al., 2011; Johnson and Woodford,
2013) carry out hydrolysis of a large spectrum of antibiotics
(Livermore, 2008) in Gram-negative bacteria.
Besides antibiotic resistance, bacteria can also exhibit
resistance against biocides such as antiseptics, disinfectants and
sanitizers due to their widespread use, by applying similar
mechanisms as against antibiotics (Russell, 1999; Poole, 2002;
Morita et al., 2014). Possible links between biocide resistance and
antibiotic resistance are a major concern as it could exacerbate
situation of increased resistance in clinically relevant organisms
(Fraise, 2002).
EVOLUTION OF ANTIBIOTIC
RESISTANCE AND ITS DISSEMINATION
Antimicrobial resistance is a natural phenomenon that bacteria
exhibit against natural antibiotics for their survival (Sheldon,
2005). Antibiotic resistance gained attention during the mid of
20th century with the development of resistance against the first
Frontiers in Microbiology | www.frontiersin.org 2 January 2017 | Volume 8 | Article 70
fmicb-08-00070 January 30, 2017 Time: 9:57 # 3
Sachdeva et al. Group 1 CPS Surface Assembly Machinery
FIGURE 1 | Antimicrobial resistance mechanisms. Schematic illustration about (A) impermeability for antibiotics (for example, a, b, and c) through outer
membrane due to channel (golden colored cylinder) selectivity, (B) efflux (dotted arrow) of penetrated (solid arrow) antibiotics across the outer membrane (golden
colored) by efflux pumps (white cylinder) (C) altered gene expression such as overexpression of porins that exhibit selectivity for antibiotics and efflux pumps (D)
target site protection through the addition of chemical groups by chemical modifiers (top–right) and mutation in the target site (bottom–right) to prevent the binding of
antibiotics to the target (dotted box, left) and (E) degradation (left) or chemical modification (right) of antibiotics by enzymatic activity to prevent its binding with the
target.
antibiotic penicillin. Many drugs have become ineffective soon
after their arrival on the market due to their overuse and misuse,
which have led to the global health crisis (Unemo and Nicholas,
2012).
Clinical, agricultural and environmental factors (Cattoir et al.,
2007) are the three major sources that facilitate the development
of antibiotic resistance. Intensive use of a broad range of
antibiotics in human, agricultural and veterinary medicine
without precise diagnostics exerts selective pressure on the
bacteria, which can give rise to a gene that confers resistance to
an antibiotic. One such example is emergence of mutations in
porin genes in E. coli due to carbapenem exposure (Tangden et al.,
2013).
Other sources that aid in the emergence of antibiotic
resistance are laboratories carrying out genetic manipulation,
pharmaceutical industries, wastewater habitats, poultry wastes
and livestock wastes. Pharmaceutical industries, wherein,
microorganisms are involved in the production of antibiotics,
expose the local microbiota to the antibiotic and motivate
AMR gene selection. Residual antibiotics present in poultry and
livestock wastes, sewage treatment plants exert pressure for the
selection of AMR genes (Fletcher, 2015). Though wastewater
treatment plants reduce the AMR bacteria, it may lead to MDR
(Cantas et al., 2013).
Evolved AMR gene(s) can subsequently be disseminated
to human pathogens through food (Founou et al., 2016),
environment (Radhouani et al., 2014) and direct or indirect
contact with livestock industry (Singer et al., 2016) through
horizontal gene transfer. One such evidence is transmission
of resistance genes from aquatic environment: similarity
between AMR genes in fish (Aeromonas) and human (E. coli)
pathogens (Sørum, 2006). Similarly, OXA-48-type carbapenem-
hydrolyzing β-lactamase genes leading to resistance among
Enterobacterial species have been found to emerge from the
chromosome of Shewanella species (Poirel et al., 2012). Among
the mechanisms of HGT, conjugation is the most prominent
route, wherein, DNA is transferred in a multi-step process
demanding cell to cell contact through pili or adhesins along
with other mechanisms like transformation and transduction
(von Wintersdorff et al., 2016). For instance, ampicillin resistance
in members of the Enterobacteriaceae family and tetracycline
resistance in enterococci are observed due to plasmid or
transposon mediated conjugation (Rice, 1998). Transformation
is another mechanism for HGT, in which, specific bacterium is
capable of up taking extracellular DNA (that posses antibiotic
resistance) from natural reservoir and develops resistance. For
example, in vitro experiments have revealed that gyrA and parC
genes responsible for fluoroquinolone resistance are transformed
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FIGURE 2 | Schematic illustration corresponding to various virulence factors of Gram-negative bacteria. Bacterial surface associated polysaccharides
that are covalently or non-covalently bound to outer membrane proteins (CPS), linked to lipid A (LPS) and loosely attached to the surface (EPS) which help the
bacteria to escape from host immune response, aid in bacterial colonization, offer resistance for penetration of antibiotics etc. are shown along with adhesins that
facilitate the attachment of bacteria onto the host cell. Secretion systems (I–VII) (Rasko and Sperandio, 2010; Depluverez et al., 2016) that deliver proteins and DNA
to extracellular region or into the target cells is represented by a cylinder.
between Streptococcus pneumoniae (Ferrandiz et al., 2000) and
several Streptococci viridans (Gonzalez et al., 1998). It has been
speculated that transduction may be playing an important role
in generating novel methicillin-resistant Staphylococcus aureus
(MRSA) strains (Barlow, 2009).
Cross-border and cross-continental human mobility (Arya
and Agarwal, 2011; Cheng et al., 2012) is also one of the
causes for the spreading of bacterial AMR gene as seen in
K. pneumoniae ‘resistance gene movement’ (McKenna, 2013).
K. pneumoniae carbapenemase (KPC)-producing bacteria that
were initially found in North Carolina (2000) soon spread to
New York in 2003. By 2005, the resistance strain was found
in Israel, from where, it traveled to Italy, Colombia, United
Kingdom and Sweden.
BACTERIAL VIRULENCE MECHANISMS
AND ANTI VIRULENCE STRATEGIES
As the use and misuse of antibiotics have lead to the selection
of antibiotic resistant organisms, it mandates the development
of alternative strategies to treat bacterial infections (Cantas
et al., 2013). In general, bacteria evolve resistance against a
drug because antibiotics are designed to either kill the bacteria
or prevent their growth (Kohanski et al., 2010) by disrupting
the biosynthesis and assembly of an essential cellular pathway.
This exerts substantial stress on the bacterium to evolve
AMR gene. Considering these, one can think of alternative
strategies that can reduce the selective pressure on the bacteria
by interfering with the mechanisms that are not essential
for their survival such as bacterial virulence and intercellular
communications.
Soon after the bacteria detects the host cell by recognizing
host signals in the environment, they initiate the self-defense
mechanism to activate the virulence traits to attach and invade
the host, evade host immune response and infect the host.
Major bacterial virulence factors (Figure 2) are: toxins, adhesins
(Rasko and Sperandio, 2010), capsular polysaccharides (CPS),
lipopolysaccharide (LPS) and exopolysaccharide (EPS) that aid
the bacteria to attach onto the host cell, escape from host immune
response, cloak sub capsular epitopes on the bacterial surface
and colonize (Wu et al., 2008). These components are being
exported to the bacterial surface or host cell using sophisticated
proteinaceous nanomachines like type I to type VII secretion
systems (Abdallah et al., 2007; Rasko and Sperandio, 2010;
Filloux, 2011) and CPS, LPS and EPS exportation systems.
Thus, interfering with the mechanisms that bacteria use for
sensing the host or preventing the expression or action of
virulence factors could control bacterial virulence. Consequently,
the host can be able to combat the infection through its immune
response.
Aforementioned virulence factors utilize diverse
supramolecular nanomachines for their surface expression
and attachment. This mandates knowledge about the structure
of nanomachinery components and intercomponent interaction
mechanisms to establish the molecular architecture of
nanomachines and the concomitant virulence factor exportation
mechanisms.
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In this review, we focus on the structure and assembly of
E. coli CPS or K-antigen exportation machinery that facilitates
the surface expression of CPS. As CPS is crucial for bacterial
pathogenicity, it can be a good vaccine/drug target.
Escherichia coli
Escherichia coli is a Gram-negative bacteria that belongs to
Enterobacteriaceae family and is a common cause for urinary
tract infections (including infections of the kidney), bloodstream
infection, diarrhea (Croxen et al., 2013) foodborne infections,
intra-abdominal infections such as peritonitis, skin and soft
tissue infections, and neonatal meningitis. Periodic outbreaks
of E. coli strains such as O121, O26, O104, O145, and O157
take place, including the outbreak of E. coli O157 that happened
in 2016 through alfalfa onion sprout products in the US1,2.
Due to its genetic flexibility and adaptability to constantly
changing environments, E. coli easily acquires a great number of
AMR mechanisms, thus, treating the infections become difficult
(Szmolka and Nagy, 2013). For instance, Center for Disease
Control and Prevention (CDC) has listed O157:H7 strain of
E. coli as a potential bioterrorism agent. Survey among 194
WHO member states in 2014 clearly indicates that E. coli has
evolved resistance against third-generation cephalosporins and
fluoroquinolones, the two major antibacterial drugs that are
currently used to treat E. coli infections (WHO, 2014). Reports
on ‘emergence of carbapenem resistance’ in E. coli (Hong et al.,
2005) are quite alarming, as it is the antibiotic of ‘last resort’
(Papp-Wallace et al., 2011).
CELL SURFACE ASSOCIATED
GLYCOCONJUGATES IN E. coli
Like many other Gram-negative bacteria, cell surface
glycoconjugates encapsulate E. coli and play crucial role in
interaction with the environment. Three major groups of
secreted polysaccharides are LPS (Putker et al., 2015), CPS or
K-antigen (Whitfield, 2006) and EPS (Whitfield et al., 2015).
LPS consists of lipid A, core polysaccharides and O-antigen
polymer, wherein lipid A moiety facilitates the covalent
insertion of LPS into the outer leaflet of outer membrane
(Figure 2). CPSs are high-molecular weight polysaccharides
that are covalently/non-covalently attached to cell. On the
other hand, EPS is loosely in association with the cell surface,
and are usually secreted to the extracellular environment to
facilitate biofilm formation (Yuan et al., 2013). Among these
three surface associated polysaccharides, O and K-antigens
are serotype-specific. In E. coli, the combination of ∼170
O-antigens and ∼80 K-antigens along with H-antigens gives
rise to 50,000–100,000 or more different serotypes (Ørskov






K-antigens are one of the major virulence determinants of
E. coli that help the bacteria to escape from the bacterial host
immune response (Whitfield, 2006). The degree of virulence
depends on the size and composition of the capsule (Horwitz and
Silverstein, 1980). CPS plays a role in defending bacteria from
phagocytosis that is a part of host’s innate immune response.
It prevents activation of the phagocytic process by decreasing
the binding of opsonins, and by masking ligands for phagocytic
cell attachment. For example, the E. coli K1 antigen binds to
C4b-binding protein (C4BP) – a major inhibitor of the classical
complement pathway (Maruvada et al., 2008). Capsules can
mask the underlying antigenic structures of the bacteria, thereby
making them less susceptible to the host’s immune system.
CPS could be structurally similar to host cell polysaccharides
and thereby a host could tolerate the bacteria owing to poor
immunogenicity. For example, K1 CPS is structurally identical
to neural cell adhesion molecule (N-CAM) (Roberts, 1996). It
further aids the bacteria to adhere to the host and also in biofilm
formation. Cationic antimicrobial peptides have microbicidal
properties against many pathogens (Fleitas and Franco, 2016).
These peptides disrupt the bacterial membranes and lead to lysis
of the cell. CPS, being anionic binds these peptides and prevents
the cell lysis (Band and Weiss, 2015). Figure 3 illustrates all the
above-discussed mechanisms.
Capsular polysaccharide also facilitates AMR in Gram-
negative bacteria by offering barrier for antibiotics to diffuse into
the host cell. A role of CPS in offering resistance to antibacterial
peptide and proteins in Gram-negative bacteria is well established
(Campos et al., 2004; Llobet et al., 2008). For instance, increased
exposure to antibiotic peptides increased the production of
CPS by upregulating the expression of the associated genes.
Sublethal use of kanamycin and streptomycin in E. coli have been
demonstrated to increase CPS production and thickness that
eventually reduced the penetration of antibiotics into the cell (Lu
et al., 2008). Several successful attempts have been made to inhibit
the biogenesis of CPS using anticapsule small molecule inhibitors
in E. coli (Goller and Seed, 2010). CPS based vaccines against
E. coli infections are also underway (Brumbaugh and Mobley,
2012; Hutter and Lepenies, 2015; Mobley and Alteri, 2015).
Escherichia coli K-antigens can be classified into four groups
on basis of genetic and biochemical criteria, namely, Group
1, Group 2, Group 3, and Group 4. While Groups 1 and
4 utilize Wzy-dependent pathway, Groups 2 and 3 use ATP-
dependent pathway for surface exportation and anchorage of
K-antigen. We aim to provide insights about the structure,
function and assembly of proteins involved in Wzy-dependent
Group 1 K-antigen exportation pathway. As the CPS exportation
machinery spans the inner and outer bacterial membranes, it can
be easily accessible for the drug molecules and thus, can be a good
target. Additionally, disrupting the surface anchorage of CPS is an
attractive strategy. Thus, detailed molecular insights about Group
1 K-antigen exportation machinery would ease the anticapsule
drug design. Nineteen K-antigens, namely, K26, K27, K28, K29,
K30, K31, K32, K33, K34, K35, K36, K37, K39, K41, K42, K43,
K55, K102, and K103 come under Group 1 classification and
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FIGURE 3 | Schematic representation of various functions of Gram-negative bacterial capsular polysaccharide. From clockwise direction: Offering
physical barrier to antibiotics, preventing bacterial cell desiccation due to hydrated nature, facilitating the bacteria to adhere onto host cell surface, helping the
bacteria to escape from host immune response by inhibiting complement cascade, preventing antibody opsonization, precluding the recognition by macrophage,
mimicking host molecules and inhibiting the penetration of cationic antibiotics by binding with it.
are negatively charged due to the presence of uronic acid and/or
pyruvate (Kunduru et al., 2016).
OVERVIEW OF THE Wzy-DEPENDENT
PATHWAY
Surface expression of K-antigen is a multistep process
(Figure 4A) that commences in the cytoplasm by attaching
the nucleotide diphospho sugar precursor [commonly,
uridine diphosphate (UDP) attached with the corresponding
hexopyranose monosaccharide of the K-antigen] to the
undecaprenyl phosphate (Und-P) carrier lipid at the
cytoplasmic face of the inner membrane. Subsequently, the
other monosaccharaides of K-antigen repeating unit are
sequentially glycosylated to form hexopyranose-PP-UndP with
the help of glycosyltransferases (WbaZ, WcaO and WcaN)
(Whitfield and Paiment, 2003). Lipid linked oligosaccharide is
then transported across the inner membrane and the repeating
unit is polymerized at the periplasmic region with the help of
an integral membrane protein Wzy, hence, acquiring the name
Wzy-dependent pathway (Whitfield, 2010), synonymously,
Wzx/Wzy pathway (Whitney and Howell, 2013) (Figure 4A).
Strikingly, EPS also utilizes Wzy dependent pathway for
its surface expression (Whitney and Howell, 2013). Thus,
understanding the Wzy-dependent pathway may shed light
not only on CPS surface expression, but also, on EPS surface
expression. As CPS also undergoes chemical modifications
akin to EPS (that eventually increases bacterial pathogenicity),
detailed insights about the Wzy pathway is warranted to
understand the mechanism behind the surface expression of
chemically modified CPS and its role in bacterial virulence
(Whitfield et al., 2015). In this context, this review explains E. coli
K-antigen surface expression by considering K30 as a case in
point.
In total, there are 12 proteins involved in K30 antigen
repeat biogenesis, polymerization, transportation and its surface
anchorage (Figure 4). The genes responsible for these proteins
are clustered together in a 16 kb cluster called cps (Figure 4B).
While the genes upstream in the cluster code for high
level polymerization, export and assembly of CPS, the genes
downstream code for the proteins involved in CPS repeat unit
synthesis and polymerization (Rahn and Whitfield, 2003). This
process happens in a sequential manner through proteinaceous
supramolecular nanomachinery (Drummelsmith and Whitfield,
1999; Rahn et al., 2003). Below are the known structural and
functional insights about all the proteins involved in Wzy-
dependent pathway.
WbaP: A TRANSFERASE
WbaP is an integral membrane protein that belongs to
polyisoprenyl-phosphate hexose-1-phosphate transferases
(PHPTs) family of enzymes that initiates the assembly of
K-antigen components at the cytoplasmic face of the inner
membrane. WbaP is involved in initiation of O-antigen synthesis
in Salmonella enterica and CPS biosynthesis in E. coli K30
Frontiers in Microbiology | www.frontiersin.org 6 January 2017 | Volume 8 | Article 70
fmicb-08-00070 January 30, 2017 Time: 9:57 # 7
Sachdeva et al. Group 1 CPS Surface Assembly Machinery
FIGURE 4 | (A) Schematic representation of group 1 CPS biosynthesis and surface exportation machinery. WbaP (initiating transferase), WbaZ (glycosyltransferases
(GT)), WcaN (GT) and WcaO (GT) located in the inner membrane and aids in biosynthesis of CPS repeating unit. Wzx, a flippase, is involved in flipping the repeat unit
from cytoplasmic region to periplasmic space and Wzy, a copolymerase, participates in the polymerization of oligosaccharide repeating unit. Inner membrane
proteins, Wzb (phosphatase) and Wzc (tyrosine autokinase) work synergistically with outer membrane protein Wza (translocon) to export CPS to the bacterial
surface. Wzi (lectin and porin) anchors CPS onto the bacterial outer membrane. (B) E. coli group 1 K30 CPS locus located in between galF and gnd on E69
chromosome (Rahn et al., 1999). wbaP, wbaZ, wcaN and wcaO code for transferases that are involved in the biosynthesis of CPS repeating unit, wzx and wzy code
for proteins involved in polymerization and wza, wzb and wzc code for proteins involved in translocation of CPS across membranes. wzi (formerly called orfX) codes
for protein that facilitates anchorage of the polysaccharide onto the outer membrane. Functions of orfY and orfZ remain unclear.
(Patel et al., 2012b). It catalyzes the transfer of galactose-1-
phosphate sugar (Gal-1-P) from uridine diphospho galactose
(UDP-Gal) by establishing phosphoanhydride bond formation
with undecaprenyl-phosphate (Und-P) lipid carrier with
concomitant release of uridine monophosphate (UMP) (Patel
et al., 2010, 2012a). Based on the topology and functional studies
of S. enterica WbaP corresponding to Wzy-dependent O-antigen
biosynthesis and surface expression (Patel et al., 2010), one
can envisage that E. coli Group 1 WbaP can also have five
transmembrane segments (Figure 5A) based on the sequence
alignment (Figure 5B). As in S. enterica, while the N-terminal
domain help in insertion of the protein into the inner membrane,
the C-terminal domain regulates the Gal-1-P transferase activity
and specificity for Und-P (Saldias et al., 2008; Patel et al., 2012a).
As WbaP has no eukaryotic homolog (Saldias et al., 2008), it can
be a good drug candidate.
Wzx: A FLIPPASE
The Und-P attached K-antigen repeating unit is transported
across the inner membrane with the help of an integral inner
membrane protein Wzx, a flippase (Whitfield, 2006). It belongs
to the family of polysaccharide-specific transport (PST) proteins
and is designated as PST-1 due to its involvement in translocating
the K-antigen repeating unit from the cytoplasmic leaflet to
periplasmic leaflet. Hitherto, there is no experimentally derived
3-dimensional structural information available for E. coli Group
1 K-antigen Wzx. However, an earlier study about O-antigen
specific Wzx (Marolda et al., 2010) has highlighted significant
features about the topology and functionally critical amino acids
of Wzx involved in O-antigen transport in E. coli O157. The study
has also identified the importance of D85, D326, R298, and K419
by mutating to alanine or serine that resulted in the expression
of Wzx that is unable to support O-antigen production (Marolda
et al., 2010). Further, this study has proposed that charge and
spatial position of these critical residues are important to let the
Und-PP-linked oligosaccharide to translocate.
Wzx falls under 1 of 4 families in multidrug/oligosaccharidyl-
lipid/polysaccharide (MOP) superfamily (Hvorup et al., 2003).
Thus, a very recent study (Islam et al., 2013) has modeled
the structure of Wzx involved in LPS surface exportation in
Pseudomonas aeruginosa using the structure of NorM protein
of Vibrio cholera O1 El Tor, a multidrug and toxin extrusion
(MATE) family of inner membrane eﬄux protein, as a template
(Islam et al., 2010, 2012). The authors have used the previously
mentioned similarity between MATE family and PST family
proteins to propose a model for Wzx flippase activity in
P. aeruginosa and suggested antiport mechanism for UndPP-
linked oligosaccharide flipping (Islam and Lam, 2013).
Encouraged by the above, Group 1 K30 Wzx is modeled
here (Figure 6A) using fold recognition based server I-TASSER
(Yang et al., 2015). The model is quite similar to the O-antigen
Wzx of P. aeruginosa with 12 transmembrane helices, despite
the poor sequence identity of 13%. Thus, as proposed by Islam
and Lam (2013), the antiport mechanism may also be applicable
here, specifically in the context of negatively charged Group
1 polysaccharide (Figure 6B). Cation (H+/Na+) binding to
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FIGURE 5 | (A) Topology map of WbaP of E. coli K30 serotype (ACCESSION: AAD21565). It is predicted to have five transmembrane helices in accordance to
prediction made for WbaP of Salmonella enterica (Saldias et al., 2008). Note that topology maps are predicted and generated using Protter server (Omasits et al.,
2014). (B) Multiple sequence alignment showing highly conserved nature of WbaP among S. enterica, E. coli, K. pneumoniae, and K. oxytoca.
FIGURE 6 | Structure of Wzx and the associated Und-P (colored purple) attached oligosaccharide flipping across the inner membrane (golden
colored surface). (A) Cartoon representation of I-TASSER (Yang et al., 2015) predicted structure of E. coli K30 Wzx by using NorM protein from V. cholera (PDB
3MKU) as a template. (B) Schematic representation of oligosaccharide repeat ‘antiport’ flipping mechanism by Wzx as proposed by Islam and Lam (2013). H+/Na+
ions (yellow spheres) located in (left) the periplasmic side binds to Wzx (middle), and subsequently opens up the cytoplasmic side of Wzy and moves toward
cytoplasmic side by exchanging Und-P attached oligosaccharide repeating unit to the periplasmic side (right).
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FIGURE 7 | (A) Topology map of Wzy E. coli K30 serotype (ACCESSION: AAD21566) is predicted to have eleven transmembrane helices. (B) ‘Catch and release’
mechanism involved in the oligosaccharide polymerization by Wzy (golden colored) (Islam et al., 2011). (Left) Und-P attached oligosaccharide that is flipped to
periplasmic side by Wzx (Figure 6) is fetched by loop 3 of Wzy (left, solid arrow) and undergoes conformational changes so as to bring the oligosaccharide repeating
unit close to loop 5 (Middle), wherein, the nascent CPS is being held. Consequently, the oligosaccharide repeating unit is transferred from loop 3 and attached to the
nascent CPS by leaving Und-PP (Right). The above reaction takes places in a cyclic manner through distributing mode.
periplasmic face of the Wzx brings conformational changes,
that subsequently facilities the opening of cytoplasmic face, and
the binding of UndPP-linked oligosaccharide to Wzx. Upon
UndPP-linked oligosaccharide binding, Wzx reverts back to
periplasmic open state conformation and releases UndPP-linked
oligosaccharide to inner membrane leaflet. This is concomitant
with the release of Wzx bound cations to cytoplasm.
Wzy: A POLYMERASE
Wzy is the polymerase that is present in the inner membrane
(Whitfield, 2010) and has been suggested to have 9–12
transmembrane segments depending on the serotype along with
a large periplasmic loop (Figure 7A) (Daniels et al., 1998;
Islam et al., 2010). It has been shown that in the case of
E. coli K30 serotype, knockout of Wzy lacks CPS, implicating
its importance in CPS surface expression (Drummelsmith
and Whitfield, 1999). Wzy is required for polymerization of
undecaprenyl diphosphate-linked K-antigen sugar moiety in the
periplasmic region. It has been proposed that Wzy polymerizes
the repeating oligosaccharide that has been translocated by
Wzx in a blockwise manner (Whitfield, 2006). Subsequently, it
releases the K-antigen oligosaccharide sugar moiety from its lipid
carrier to the nascent polymer (Schild et al., 2005). This coupled
functionality of Wzx translocation and Wzy polymerization in
the context of surface associated polysaccharides has lead to name
“Wzx/Wzy pathway” (Schmid and Sieber, 2015) or “Wzx/Wzy
secretion system” (Whitney and Howell, 2013). A recent study
on O86 antigen polymerization in E. coli Wzy dependent
pathway proposes that Wzy adopts a distributive mode of repeat
oligosaccharide polymerization, wherein, after each round of
repeat polymerization the enzyme dissociates from the nascent
CPS and randomly binds to the repeat oligosaccharide to carry
out the reaction in a cyclic manner (Zhao et al., 2014). Another
study carried out on P. aeruginosa PAO1 suggests a “catch
and release” model (Figure 7B). According to this model, the
periplasmic loop 3 captures the repeating oligosaccharide and
periplasmic loop 5 performs the polymerization and substrate
release activities (Islam et al., 2011, 2013).
Wzc: AN INNER MEMBRANE TYROSINE
AUTOKINASE
Nascent K-antigen is then translocated onto the bacterial surface
by synergetic action of Wza, Wzc, and Wzb (Cress et al., 2014),
(Figures 4A and 8) whose length and amount are controlled
by Wzc and Wzb (Morona et al., 2000; Obadia et al., 2007).
Wzc, is a bacterial tyrosine (BY) autokinase that also functions
as a copolymerase by regulating the length of the polymer
together with Wzb, its cognate phosphatase. wzc gene codes for
a copolymerase that belongs to polysaccharide copolymerase 2a
(PCP-2a) subfamily which is required for the assembly of Group
1 capsule (Cuthbertson et al., 2009). Though Wzy is capable of
polymerizing the sugar moieties, Wzc and Wzb are shown to be
essential for longer K-antigen structure (Collins et al., 2006).
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FIGURE 8 | Diagram illustrating the interacting mode of Wza, Wzc, and Wzb that are involved in CPS surface exportation. While Wza (PDB ID: 2J58)
spans the periplasmic and outer membrane regions, Wzc spans periplasmic, inner membrane and cytoplasmic regions. Crystal structure of Wzc cytoplasmic
domain (PDB ID: 3LA6) is represented in cartoon, whereas, its periplasmic and inner membrane regions are represented by black colored dotted loops and solid
helixes respectively. In line with the ocatmeric form of cytoplasmic Wzc, periplasmic and inner membrane regions are also given as octamers. Wzb located in
cytoplasmic region is shown in dotted box. It is to be noted that membrane is shown in orange surface representation. Note: Wza- Wzc interaction is based on
model proposed by Collins et al. (2006).
Wzc is an integral membrane protein consisting of two
transmembrane helices (32–52 and 426–445 residues) flanking a
large periplasmic domain (53–425 residues) and a cytoplasmic
C-terminal region (446–720 residues) (Doublet et al., 2002)
containing an extended tyrosine-rich tail (seven tyrosine residues
within last 17 amino acids). Cytoplasmic domain (Figure 9A)
has Walker A and B motifs which are involved in ATP binding
and hydrolysis (Wugeditsch et al., 2001; Cuthbertson et al., 2009).
The domain also has a phosphate binding loop (P-loop), a general
characteristic of nucleotide binding P-loop proteins.
Wzc autophosphorylates the C-terminal tyrosine cluster
(Y-cluster) to regulate the polymerization of the nascent
K-antigen. This happens in association with oligomerization
of Wzc. The process is initiated with autophosphorylation of
Y569 and followed by transphosphorylation of Y-clusters in
neighboring monomers (Wugeditsch et al., 2001; Standish and
Morona, 2014). However, the precise mechanism about how
autophosphorylation of Wzc in cytoplasmic C-terminal Y-cluster
controls the length of K-antigen in the periplasmic region
is poorly understood. Wzc knockout or compromise on its
phosphorylation such as deletion of Y-cluster is shown to halt the
polymerization and surface expression of K-antigens (Paiment
et al., 2002).
In the crystal structure of cytoplasmic tyrosine autokinase
domain of E. coli K12, Wzc exists in ring-shaped octameric
form with Y-cluster in non-phosphorylated state (Bechet et al.,
2010). In Figure 9A, Wzc is complexed with ADP, such that
the tyrosine rich region of one monomer is inserted onto
the active site of another. This has led to the assumption
that in the non-interactive state of the Wzc cytoplasmic
domains, Y-cluster is in phosphorylated state that could
be easily dephosphorylated by Wzb to promote interaction
between Wzc cytoplasmic domains (Wugeditsch et al., 2001;
Standish and Morona, 2014). Nonetheless, divergent evidence
exists about the relationship between phosphorylation (non-
interactive)/dephosphorylation (interactive) of Wzc and its
copolymerase activity (Wugeditsch et al., 2001; Standish and
Morona, 2014). While some support that phosphorylated Wzc
promotes polymerization, others suggest the reverse. In any
case, cycling between the two states is essential to regulate the
K-antigen biosynthesis.
Transmission electron microscope (TEM) map of Wzc-
Wza complex (Collins et al., 2006, 2007) shows that Wzc
directly interacts with octameric Wza in oligomeric form at
the periplasmic region (Wugeditsch et al., 2001). In Wzc-Wza
complex TEM map, Wzc resembles an extracted molar tooth
where the crown is formed by periplasmic region and cytoplasmic
tyrosine autokinase domain makes up the roots (Collins
et al., 2006). However, more detailed structural investigation is
warranted due to the difference in the level of oligomerization
of Wzc: octameric crystal structure (Bechet et al., 2010) versus
tetrameric TEM structure (Collins et al., 2006, 2007). The level
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FIGURE 9 | Wzc and Wza structures. (A) Top view of Wzc cytoplasmic domain is shown in cartoon (right) and surface (left) representations. Two interacting Wzc
monomers are magnified (boxed) to show the Walker A motif (ATP binding site; represented cyan), Y569- the first autophosphorylated tyrosine (represented in yellow
stick) and C-terminal Y-cluster (blue colored stick) along with the first transphosphorylated Y715 that is inserted into the adjacent monomer. ADP (orange colored
stick) bound to its Walker A motif site is also shown. (B) Extracellular (right) and periplasmic (left) views of Wza. Trp350 on extracellular side (right) and Tyr110 at
periplasmic side (left) are indicated by yellow colored spheres and orange colored sticks respectively. Note that Tyr110 seals the periplasmic entry.
of phosphorylation of the C terminal tyrosine residues (seven
residues) may determine the oligomerization state of Wzc.
Wzb: PHOSPHOTYROSINE
PHOSPHATASE
Degree of polymerization of nascent K-antigen is controlled
by the combined action of Wzc and Wzb, a cognate low
molecular weight phosphotyrosine phosphatase (LMW PTP)
(Standish and Morona, 2014). Located in cytosol, Wzb
dephosphorylates the tyrosine residues present in the Wzc
Y-cluster. However, detailed mechanism behind this process
is not known, due to the lack of structural information
about Wzc-Wzb complex. A model suggests that for continued
polymerization of the sugar repeating units, phosphorylation
and dephosphorylation of C-terminal tyrosine residues of Wzc
by Wzb are required (Whitfield, 2006). Indeed, mutation
in Wzb resulted in an acapsular phenotype (Wugeditsch
et al., 2001), implicating its importance in capsule surface
expression.
Crystal structure (PDB:2WJA) of K30 E. coli Wzb coincides
well with typical LMW PTP of eukaryotes with 4 β–strands
(β 1–4) that consists of residues Ser8-Cys13, Lys34–Gly40,
Leu80–Val85 and Thr104–Leu106 respectively and five α-helices
(Hagelueken et al., 2009a) (α 1–5) that encompasses residues
Cys18–Arg29, Asp50–Arg55, Thr73–Arg78, Glu87–Gly103 and
Ser124–Lys145 respectively. The tertiary structure has parallel
β strands surrounded by α1, α2, α5 on one side and α3,
α4 on the other side with three loops connecting β2-α2, α2-
α3 and β4-α5. The structure also reveals the presence of
C(X)5RS motif (P-loop), a hallmark of cysteine-dependent PTP
FIGURE 10 | (A) Crystal structure of Wzb of E. coli K30 serotype bound with
PO4 (PDB ID: 2WJA). Nucleotide binding P loop is colored in orange. PO4
and Cys13 are represented in green and blue colored sticks respectively.
(B) Superimposed structures of Wzb of K30 (crystal structure, PDB ID: 2WJA,
colored red) and K12 (Structure derived from NOE based distance restraints
and RDC based orientational restraints, PDB ID: 2FEK, colored green)
serotypes exhibit high structural similarity with root mean square deviation of
0.8 Å (Hagelueken et al., 2009a). Thus, the phosphatase mechanism
proposed for K12 Wzb can also be applicable to K30 Wzb.
superfamily. The crystal structure of phosphate bound E. coli
Wzb (Figure 10A) clearly shows that cysteine 13 located in
the active site cavity is the catalytic nucleophile that attacks
the phosphate group of tyrosines in Wzc and dephosphorylates
it. Catalytic mechanism proposed involves conserved positively
charged Arg 19 which binds to incoming phosphate, followed by
the displacement of tyrosine by the Cys 13 thiol and protonation
of tyrosine is done by Asp119 or Cys18 (Hagelueken et al.,
2009a). The final step involves hydrolysis of thiophosphate
ester by a water molecule, activated by Asp119, leading to the
generation of free phosphate and the regeneration of the thiol in
Cys 13.
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K30 E. coli Wzb structure (PDB:2WJA) exhibits significant
structural similarity with K12 E. coli Wzb (PDB: 2FEK) (Lescop
et al., 2006) with 0.8Å root mean square deviation (Figure 10B).
The study also reveals through NMR based phosphate titration
experiments that phosphate binding Wzb leads to structural
rearrangement in Cys13 and other coordinating residues (Cys9–
Asn12, Cys14–Ser16, Glu20, Gly36, Leu37, Leu40, Arg66 and
Tyr117).
Structural comparison of eukaryotic and prokaryotic LMW-
PTPs has revealed that substrate recognition mechanism is
different between them, thus, can be exploited for drug design
that is more specific toward prokaryotic PTPs than host
phosphatases (Lescop et al., 2006). For instance, eukaryotic
LMW-PTPs have phosphotyrosine sandwiched between two
aromatic rings (Tyr131 and Trp49 in humans and bovine)
whereas Wzb has Tyr117 (equivalent to human Tyr131) and
doesn’t have Trp49 equivalent. Wzb has shorter α2-β2 loop
which marks the difference in substrate recognition. In addition,
prokaryotic Wzb recognizes C-terminal tyrosine rich tail of
Wzc whereas eukaryotic counterparts recognize a single tyrosine
residue edged by charged amino acids.
Wza: AN OUTER MEMBRANE
TRANSLOCON
Wza is an outer membrane translocon that translocates the
nascent CPS onto the bacterial surface (Beis et al., 2004;
Hagelueken et al., 2009b) (Figures 8 and 9B). In fact, recently
it has been shown that CPS exits through Wza portal (Nickerson
et al., 2014). Knockout of wza has been shown to be ineffective
in exporting CPS (Nesper et al., 2003; Dong et al., 2006). Wza
exists in octameric form (Drummelsmith and Whitfield, 2000;
Ford et al., 2009) spanning 140 Å along the periplasmic and
outer membrane regions. Acylation at the N-terminal cysteine is
important for the octamerization of the protein (Nesper et al.,
2003). Octamerization of Wza results in a wider lumen so as to
facilitate the surface exportation of CPS and the overall structure
of Wza resembles an amphora without a handle (Dong et al.,
2006). Bulk of the protein is located in periplasmic space and it
also has a novel α-helical transmembrane region (Collins et al.,
2007).
There are four domains in the Wza monomer. Upon
octamerization, these domains individually form four different
rings: I, II, III, and IV. First domain, located in the periplasmic
region, comprises of 89–169 residues, which folds into novel
anti-parallel β-sandwich with α-helix at one edge constitute
ring I. It has an occluded center due to the presence of eight
loops. Tyrosine 110 located at the tip of each loop has flexible
side chain that is responsible for blocking the pore. Second
domain consists of residues 68–84 and 175–252, eight copies
of which forms ring II with 25 Å diameter. This domain has
a central five-stranded mixed β-sheet with three α-helices on
one side. Octamerization of domain three forms ring III with
an external diameter of 105 Å. It comprises of residues 46–
64 and 255–344. Domain four is the carboxy terminal (345–
376 residues) α-helical transmembrane region. This domain
sits just above domain three and forms ring IV with internal
diameter of 30 Å, which tapers to 17 Å at the open end. Both
the central cavity and external surface of first three domains
are polar in nature in sync with nature of periplasmic region,
while the external surface of α-helical barrel is hydrophobic in
nature with tryptophan 350 exposed at the surface (Dong et al.,
2006).
Concave surface at the bottom has a conserved polysaccharide
export sequence (PES) domain that confers it to be potential
site for Wzc–Wza interaction (Collins et al., 2007). It has been
found that interaction of Wzc with Wza (Reid and Whitfield,
2005) helps in opening of the closed surface in ring I thus,
helping in the transport of nascent polysaccharide through Wza
to the cell exterior. However, it has been shown that Wzc doesn’t
play any role in the assembly of Wza (Nesper et al., 2003).
Defects in export of CPS make the bacterium vulnerable to host
immune system. Concomitant to this fact an effective blocker
γ-cyclodextrin, has been discovered that not only blocks Wza
channel but also enhances complement-mediated cascade (Kong
et al., 2013).
MODEL PROPOSED FOR GROUP 1 CPS
POLYMERIZATION AND SURFACE
EXPORTATION
Various aspects of Group 1 CPS exportation nanomachinery
have not been fully understood at the molecular level to
provide full mechanistic picture of CPS biosynthesis and
surface expression processes. However, existing structural and
functional data about the components of CPS exportation
machinery provide significant insights about versatility of Wza,
Wzc, and Wzb in capsule length regulation and exportation
and led us to propose a model. As the tyrosines present
in the cytoplasmic region of Wzc can be phosphorylated
or dephosphorylated (Doublet et al., 2002), it can regulate
the CPS polymerization and exportation activity in a cyclic
manner concomitant with dephosphorylation activity of Wzb
(Standish and Morona, 2014). Upon dephosphorylation by
phosphatase Wzb, Wzc exhibits copolymerase activity conjointly
with Wzy by establishing the linkage between the CPS repeating
units, thus, helping in CPS chain elongation. During this
state, cytoplasmic domains of Wzc multimer are in interactive
state (Figure 11). On the other hand, phosphorylation of
cytoplasmic tyrosines direct cytoplasmic domains to enter into
non-interactive state (Figure 11), while the periplasmic and
transmembrane domains are still in interactive state. This state of
Wzc may help in pushing the nascent polysaccharide into Wza
channel, thus facilitating polysaccharide exportation. However,
the associated conformational changes that these proteins
undergo are still unknown. Such cycling between phosphorylated
and dephosphorylated state may be needed to couple the actions
of this membrane spanning multienzyme complex to carry out
CPS biosynthesis and exportation (Olivares-Illana et al., 2008).
Further experimentation is needed to understand the missing
links to ease the exploitation of the proteins involved in Group
1 CPS exportation for next generation antibiotics.
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FIGURE 11 | Model proposed for cyclic copolymerase and CPS exportation activities of Wzc. (Left) Wzc is in dephosphorylated state with its monomers
interacting at the cytoplasmic region and performs the role of copolymerase conjointly with Wzy (colored white). (Right) Wzc is in phosphorylated state, wherein the
monomers are non-interacting at the cytoplasmic region and participates in exportation of nascent CPS along with Wza. The model is based on existing experimental
data on E. coli Wza (colored green), Wzb (colored maroon) and Wzc along with Wzc (colored blue) homolog present in polysaccharide exportation system of
S. aureus (see text for details). Note that the tetrameric state of Wzc is adopted from low-resolution electron microcopy structure of Wzc (Collins et al., 2006).
Wzi: AN OUTER MEMBRANE PROTEIN
FUNCTIONING AS A LECTION AND A
PORIN
Crystal structure of Wzi indicates that it is an 18-stranded
β-barreled outer membrane protein (Bushell et al., 2010, 2013).
The barrel has a diameter of ∼36 Å. There are nine loops on
extracellular side and 3 amphipathic α-helices and 8 turns at
periplasmic end that occlude the pore. The irregular lengths of
β strands result in a triangular “notch” at the extracellular side.
The nascent K-antigen binds to Wzi (Figure 12A) thus,
nucleating its condensation into a dense capsule (Rahn et al.,
2003). In fact, insertion mutant of Wzi either forms loosely
attached K-antigen or the capsule formation is not observed
(Rahn et al., 2003). The exact binding site for CPS on Wzi is still
unknown. However, similar to sodium galactose cotransporters,
an YQF motif is present at the extracellular side of the barrel,
suggesting that it may aid in CPS binding (Sachdeva et al.,
2016). Molecular dynamics simulations along with structure
based phylogeny show that Wzi plays a dual role, as a lectin
(sugar binding protein) and a porin (water conducting protein).
Porin property (Figure 12B) of Wzi may facilitate in keeping
the capsule in hydrated condition by acting as an osmoregulator
(Sachdeva et al., 2016). Bidirectional water specific porin function
of Wzi is justified through its structural similarity with other
porins. It has been proposed that the protein might have evolved
the lectin property when the bacteria established the self-defense
mechanism for its survival.
CPS BASED VACCINE DEVELOPMENT
Surface assembled K-antigen or CPS is a good vaccine target. The
history of CPS based vaccine began in 1920s with the discovery
of immunogenicity against CPS in Streptococcus pneumoniae
(Heidelberger and Avery, 1923, 1924). Consequently, it boosted
the discovery of many CPS based vaccines against Gram-negative
bacteria such as Neisseria meningitides, Haemophilus influenza,
and Salmonella enterica serovar Typhi (Hutter and Lepenies,
2015). Unlike antibiotics, vaccines prevent the infection. CPS
based vaccines are based on the principle of producing antibodies
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FIGURE 12 | Dual functions of Wzi. (A) Lectin function (pale-green colored cartoon) of Wzi (PBD ID: 2YNK) illustrated using K30 (red sticks) modeled structure
(Kunduru et al., 2016). (B) Water conducting (blue surface) action of Wzi (cyan colored cartoon) (Sachdeva et al., 2016). Residues that direct water conduction
across the channels are shown as yellow spheres.
against CPS by vaccinating with an attenuated CPS carrying
pathogen. In fact, in E. coli many successful attempts have been
made in line to develop CPS based vaccines (Mobley and Alteri,
2015). Very recently, a two-stage synergistic ‘vaccination and
block’ approach has been successfully used against Group 1
E. coli by conjointly targeting LPS (with vaccine) and CPS (with
blocker) (Bundle, 2016; Kong et al., 2016). In this approach, a
synthetic glycoconjugate that mimics the LPS epitope, which is
generally obscured by CPS, is used to generate the antibodies.
Subsequently, the LPS epitope is exposed for antibody attack by
simply blocking the CPS exporter (Wza) at the extracellular side
using γ-cyclodextrin to reduce the CPS exportation. However,
poor sequence similarity of Wza among various Gram-negative
bacterial strains poses major challenge to develop a universal
CPS inhibitor. Water solubility of γ-cyclodextrin is a yet another
factor to be addressed.
FUTURE PERSPECTIVE
Development of antibiotic resistance through new mechanisms
on a regular basis and its ability to transmit between various
clinically relevant strains and pathogens is a worrying and
challenging scenario. While the number of pathogens exhibiting
resistance is increasing day-by-day, the development of next-
generation antibacterial drugs to circumvent the existing
resistance mechanism is in very slow phase. As suggested by
O’Neill (2016) in AMR review, finding new antibiotic resistance
mechanisms that can be targeted, judicious use of antibiotics
in human, veterinary, and aquaculture medicine, eliminating
the use of antibiotics in agriculture and following hygienic
practice through public awareness may slowdown the evolution
of AMR, but, will not eradicate it. Though synergetic use
of different antibiotics can be useful, use of antivirulence
drugs/vaccines would help in reducing the selection pressure on
the bacteria.
Biogenesis of cell envelope is a valuable target for antivirulence
drugs in E. coli. Three mechanisms can be hampered in
this regard: biosynthesis, export and surface assembly of
polysaccharides. In E. coli Wzy-dependent Group 1 K-antigen
pathway, capsule biosynthesis and export can be prevented by
blocking the function of regulatory proteins Wzc and Wzb as
they together alter the thickness of CPS at different stages of
the infection, making them viable drug targets (Ericsson et al.,
2012). In fact, a recent study shows that knockout of wza, wzc,
and wzb offers resistance to macrolide in capsule independent
manner (Botros et al., 2015). However, a single knock out of wzb
doesn’t exhibit resistance to the macrolide erythromycin (Rana
et al., 2016). As acknowledged by the authors themselves more
systematic investigation on effect of the single and combination
of double knockouts on capsule surface expression are required
against various antibiotics against various E. coli strains to derive
a solid conclusion on this aspect.
Wza (an outer membrane translocon) and Wzi (an outer
membrane lectin and porin) are the most suitable antivirulence
targets as they are surface exposed. Both the proteins are essential
for the production of a normal physiological capsule. It has been
shown that knock out of wza offers resistance to erythromycin
Frontiers in Microbiology | www.frontiersin.org 14 January 2017 | Volume 8 | Article 70
fmicb-08-00070 January 30, 2017 Time: 9:57 # 15
Sachdeva et al. Group 1 CPS Surface Assembly Machinery
FIGURE 13 | Sequence analysis of α helical barrel of Wza. (A) Sequence alignment of Wza α helical sequences between various E. coli and Gram-negative
bacterial strains. Note that multiple sequence alignment was done using MEGA 7.0 (Kumar et al., 2016). (B) Conserved and mutated residues of alpha helical barrel
of Wza mapped onto Wza structure (boxed region). Note that while sequence identity and similarity are colored orange and gray respectively, the mutated residues
are colored yellow. High sequence conservation of amino acids at the protein - membrane interface and divergence in the sequence at the extracellular side can be
seen. (C) Structure of gamma cyclodextrin that is successfully shown to block the binding of K30 CPS to Wza.
in capsule independent manner (Rana et al., 2016). Wza can
be blocked using carbohydrate blockers such as γ-cyclodextrin
(Kong et al., 2013). However, the membrane spanning alpha
helical barrel of Wza sequence is highly diverse at the extracellular
side even among E. coli strains (Figure 13A). This poses a major
challenge in developing a universal drug molecule against Gram-
negative bacteria that uses Wzy-dependent CPS exportation
pathway, as the residues exposed to extracellular side are crucial
in dictating the binding specificity with drug molecules. This
is true despite the fact that Wza blocker like γ-cyclodextrin
can easily fit into the Wza channel: ∼13Å diameter (former)
versus 21 Å (latter) (Figures 13B,C). It is possible that chemical
modification of γ-cyclodextrin molecule would help to solve the
issue, at least to treat pathogenic E. coli.
Wzi can be ambushed in three different ways. Firstly, by
targeting its lectin property, and identifying the binding site
of K-antigen on Wzi is of paramount importance to hamper
the capsule formation. Crystal structure of Wzi (Bushell et al.,
2013) along with EK3D (Kunduru et al., 2016), a manually
curated repository of modeled E. coli K-antigen structures can
be exploited for this strategy. Secondly, disrupting the anchorage
of Wzi onto the membrane may in turn prevent the capsule
formation. Thirdly, altering water diffusion property of Wzi may
result in cell rupturing, thus killing the bacterium. Yet another
antivirulence strategy is to develop cell envelope based vaccines
to treat the infections. In fact, so far there is no Food and Drug
Administration US (FDA) approved vaccines available against
E. coli infections and only two vaccines are in Phase I clinical trial
(O’Neill, 2016). Conjoint use of antibiotics along with vaccines
may reduce the proliferation of infectious bacteria. Nonetheless,
certain issues pose challenges in developing vaccines against
surface polysaccharides. For instance, presence of a molecular
mimicry of a K-antigen in the host reduces the production of
antibodies against specific K-antigen, resulting in a vaccine with
less immunogenicity. Due to the strain diversity, designing a
surface polysaccharide-based vaccine that can be effective against
infections caused by all serotypes is extremely challenging.
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